NASDAQ · Biotechnology

BOLD (BOLD) Stock

$2.48 -3.50% NASDAQ: BOLD Healthcare

Valuation

MetricValue
Price$2.48
Market Cap$55.74M
P/E Ratio-0.56
P/B Ratio0.33
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$2.69
52-Week Low$0.96
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-58.59%
ROA-36.94%
ROCE-64.65%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.56
Current Ratio8.46

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-25.0M$-46.0M$-55.0M$-73.0M$-64.0M
Net Profit$-25.0M$-46.0M$-49.0M$-65.0M$-58.0M
EPS$-1.13$-2.06$-2.22$-3.85$-2.60
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$114.0M$77.0M$130.0M$206.0M$157.0M
Total Liabilities$152.0M$159.0M$257.0M$56.0M$58.0M
Cash$34.0M$11.0M$24.0M$27.0M$18.0M
Borrowings$0$5.0M$2.0M$48.0M$49.0M

Latest News

Why Did BOLD, BLZE, QNT Stocks Surge To 52-Week Highs Today Stocktwits · Jun 24, 2026 Sector Update: Healthcare Stocks Higher Late Afternoon MT Newswires · Jun 23, 2026 Sector Update: Healthcare Stocks Advance in Afternoon Trading MT Newswires · Jun 23, 2026 BOLD Stock Is Up 90% — Here's What's Behind The Biggest Rally In Company History Stocktwits · Jun 23, 2026 Top Midday Gainers MT Newswires · Jun 23, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-23.0M$-40.0M$-47.0M$-61.0M$-47.0M
Investing Cash Flow$-61.0M$15.0M$-39.0M$-29.0M$37.0M
Financing Cash Flow$0$0$-2.0M$-3.0M$0
Net Cash Flow$23.0M$-23.0M$13.0M$3.0M$-9.0M
Free Cash Flow$-25.0M$-41.0M$-47.0M$-63.0M$-47.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-146.13%
Quick Ratio9.87
Interest Coverage—
Return 1Y122.77%
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANTX $4.93 +0.20% -4.76 $177.56M 0.00%
INTS $4.57 +2.70% -0.60 $12.35M 0.00%
ITRMIterum Therapeutics plc $0.03 -10.98% -0.06 $1.60M 0.00%
NXTC $5.00 +17.81% -0.26 $18.04M 0.00%
PLURPluri Inc. $1.68 -5.62% -0.62 $15.11M 0.00%

About BOLD

BOLD is led by CEO Zachary Hornby, publicly traded since 2016.

BOLD stock trades at $2.48 with a market capitalization of $55.74M. The stock is valued at a price-to-earnings (P/E) ratio of -0.56, price-to-book of 0.33, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.96 and $2.69, and currently trades 7.8% below its 52-week high.

On profitability, BOLD generates a return on equity (ROE) of -58.59%, return on capital employed of -64.65%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides